EP3733163A1 - FORMULATIONS WITH ENHANCED STABILITY AND BIOAVAILABILITY FOR ADMINISTRATION OF (E)-2,6-DIALKOXYSTYRYL 4-SUBSTITUTED BENZYLSULFONES